Robert L Ferrara insider trades
Open-market stock purchases and sales by Robert L Ferrara, Director at Phio Pharmaceuticals Corp, from SEC Form 4 filings since Nov 18, 2019.
Track record: 33% of 6 scored buys are up 5% or more since purchase, averaging +15%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- PHIO Phio Pharmaceuticals Corp: 6 buys, last Sep 11, 2025